JP2009514989A5 - - Google Patents

Info

Publication number

JP2009514989A5

JP2009514989A5 JP2008551241A JP2008551241A JP2009514989A5 JP 2009514989 A5 JP2009514989 A5 JP 2009514989A5 JP 2008551241 A JP2008551241 A JP 2008551241A JP 2008551241 A JP2008551241 A JP 2008551241A JP 2009514989 A5 JP2009514989 A5 JP 2009514989A5

Authority

JP

Japan

Prior art keywords

release

loxoprofen

composition

drug

administration

Prior art date

2006-05-09

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• YMBXTVYHTMGZDW-UHFFFAOYSA-N Loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 description 127
• 229960002373 loxoprofen Drugs 0.000 description 126
• 239000000203 mixture Substances 0.000 description 106
• 239000003814 drug Substances 0.000 description 51
• 229940079593 drugs Drugs 0.000 description 50
• 230000035492 administration Effects 0.000 description 47
• 239000004480 active ingredient Substances 0.000 description 41
• 239000002552 dosage form Substances 0.000 description 39
• 229920000642 polymer Polymers 0.000 description 39
• 210000002381 Plasma Anatomy 0.000 description 37
• 239000002245 particle Substances 0.000 description 31
• 239000011248 coating agent Substances 0.000 description 26
• 238000000576 coating method Methods 0.000 description 26
• 230000036470 plasma concentration Effects 0.000 description 26
• 230000002459 sustained Effects 0.000 description 23
• 239000011159 matrix material Substances 0.000 description 22
• 239000010410 layer Substances 0.000 description 18
• 150000001875 compounds Chemical class 0.000 description 17
• 230000003111 delayed Effects 0.000 description 17
• 239000003826 tablet Substances 0.000 description 17
• 230000003204 osmotic Effects 0.000 description 16
• 229920001223 polyethylene glycol Polymers 0.000 description 16
• 238000009472 formulation Methods 0.000 description 14
• 238000009792 diffusion process Methods 0.000 description 12
• 239000011780 sodium chloride Substances 0.000 description 12
• 239000000758 substrate Substances 0.000 description 12
• 230000035832 Lag time Effects 0.000 description 11
• 230000035648 Lag-time Effects 0.000 description 11
• 150000003839 salts Chemical class 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• 238000003860 storage Methods 0.000 description 11
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
• 206010061218 Inflammation Diseases 0.000 description 10
• 208000002193 Pain Diseases 0.000 description 10
• -1 hydroxypropyl methylcellulose ethers Chemical class 0.000 description 10
• 230000001965 increased Effects 0.000 description 10
• 230000004054 inflammatory process Effects 0.000 description 10
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 10
• 239000004094 surface-active agent Substances 0.000 description 10
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
• 239000000463 material Substances 0.000 description 9
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
• 230000000694 effects Effects 0.000 description 8
• DUGOZIWVEXMGBE-UHFFFAOYSA-N Adhd patch Chemical group C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 7
• 229960001344 Methylphenidate Drugs 0.000 description 7
• 230000002902 bimodal Effects 0.000 description 7
• 239000011148 porous material Substances 0.000 description 7
• 235000021251 pulses Nutrition 0.000 description 7
• 229920002301 Cellulose acetate Polymers 0.000 description 6
• 229920003134 Eudragit® polymer Polymers 0.000 description 6
• 239000003795 chemical substances by application Substances 0.000 description 6
• YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
• 230000001225 therapeutic Effects 0.000 description 6
• 239000001768 carboxy methyl cellulose Substances 0.000 description 5
• 229920001577 copolymer Polymers 0.000 description 5
• 230000003247 decreasing Effects 0.000 description 5
• 238000004090 dissolution Methods 0.000 description 5
• 239000000017 hydrogel Substances 0.000 description 5
• 230000035699 permeability Effects 0.000 description 5
• 239000004014 plasticizer Substances 0.000 description 5
• 239000001103 potassium chloride Substances 0.000 description 5
• 235000011164 potassium chloride Nutrition 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 229920001817 Agar Polymers 0.000 description 4
• FAKRSMQSSFJEIM-RQJHMYQMSA-N Captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 4
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
• 239000001856 Ethyl cellulose Substances 0.000 description 4
• ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
• 210000001035 Gastrointestinal Tract Anatomy 0.000 description 4
• 239000004372 Polyvinyl alcohol Substances 0.000 description 4
• 229920002472 Starch Polymers 0.000 description 4
• 229940032147 Starch Drugs 0.000 description 4
• 238000010521 absorption reaction Methods 0.000 description 4
• 239000008272 agar Substances 0.000 description 4
• 235000010419 agar Nutrition 0.000 description 4
• RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
• 229960000830 captopril Drugs 0.000 description 4
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
• 230000002708 enhancing Effects 0.000 description 4
• 235000019325 ethyl cellulose Nutrition 0.000 description 4
• 229920001249 ethyl cellulose Polymers 0.000 description 4
• 235000011187 glycerol Nutrition 0.000 description 4
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
• 238000002386 leaching Methods 0.000 description 4
• 238000011068 load Methods 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 239000011859 microparticle Substances 0.000 description 4
• 230000003278 mimic Effects 0.000 description 4
• 239000006186 oral dosage form Substances 0.000 description 4
• 229920002451 polyvinyl alcohol Polymers 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 230000002829 reduced Effects 0.000 description 4
• 239000008107 starch Substances 0.000 description 4
• 235000019698 starch Nutrition 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 3
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
• XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 3
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
• 210000002784 Stomach Anatomy 0.000 description 3
• 239000002253 acid Substances 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 230000003110 anti-inflammatory Effects 0.000 description 3
• 239000011324 bead Substances 0.000 description 3
• OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 229910052791 calcium Inorganic materials 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
• 235000010980 cellulose Nutrition 0.000 description 3
• 229920002678 cellulose Polymers 0.000 description 3
• 239000001913 cellulose Substances 0.000 description 3
• 235000014113 dietary fatty acids Nutrition 0.000 description 3
• 239000006185 dispersion Substances 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 150000002148 esters Chemical class 0.000 description 3
• 239000000194 fatty acid Substances 0.000 description 3
• 239000010419 fine particle Substances 0.000 description 3
• 239000007903 gelatin capsule Substances 0.000 description 3
• 229920001477 hydrophilic polymer Polymers 0.000 description 3
• 230000002706 hydrostatic Effects 0.000 description 3
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
• 229940071676 hydroxypropylcellulose Drugs 0.000 description 3
• 229920000609 methyl cellulose Polymers 0.000 description 3
• 235000010981 methylcellulose Nutrition 0.000 description 3
• 239000001923 methylcellulose Substances 0.000 description 3
• 239000003094 microcapsule Substances 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000006011 modification reaction Methods 0.000 description 3
• 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 3
• 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 description 3
• 230000000144 pharmacologic effect Effects 0.000 description 3
• 229920000058 polyacrylate Polymers 0.000 description 3
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
• 239000011241 protective layer Substances 0.000 description 3
• KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
• 239000011734 sodium Substances 0.000 description 3
• 235000015424 sodium Nutrition 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 239000002904 solvent Substances 0.000 description 3
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
• MURWRBWZIMXKGC-UHFFFAOYSA-N 1-O-butyl 2-O-octyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC MURWRBWZIMXKGC-UHFFFAOYSA-N 0.000 description 2
• CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• 230000035639 Blood Levels Effects 0.000 description 2
• 102000008186 Collagen Human genes 0.000 description 2
• 108010035532 Collagen Proteins 0.000 description 2
• 240000005497 Cyamopsis tetragonoloba Species 0.000 description 2
• MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 2
• 229920003151 Eudragit® RL polymer Polymers 0.000 description 2
• 229920003152 Eudragit® RS polymer Polymers 0.000 description 2
• 210000004051 Gastric Juice Anatomy 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 229940014259 Gelatin Drugs 0.000 description 2
• 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
• 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
• 229920000126 Latex Polymers 0.000 description 2
• 230000035633 Metabolized Effects 0.000 description 2
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
• 210000002027 Muscle, Skeletal Anatomy 0.000 description 2
• 229940100467 POLYVINYL ACETATE PHTHALATE Drugs 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 239000004373 Pullulan Substances 0.000 description 2
• 229920001218 Pullulan Polymers 0.000 description 2
• JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 2
• 235000015125 Sterculia urens Nutrition 0.000 description 2
• 240000001058 Sterculia urens Species 0.000 description 2
• 229920001615 Tragacanth Polymers 0.000 description 2
• 229940116362 Tragacanth Drugs 0.000 description 2
• URAYPUMNDPQOKB-UHFFFAOYSA-N Triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
• 229960002622 Triacetin Drugs 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 230000002378 acidificating Effects 0.000 description 2
• 239000008186 active pharmaceutical agent Substances 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 230000000202 analgesic Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 229960001948 caffeine Drugs 0.000 description 2
• 235000001465 calcium Nutrition 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
• 229920001436 collagen Polymers 0.000 description 2
• 229960005188 collagen Drugs 0.000 description 2
• 239000002131 composite material Substances 0.000 description 2
• 238000004132 cross linking Methods 0.000 description 2
• 125000003192 dTMP group Chemical group 0.000 description 2
• 239000008367 deionised water Substances 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 238000005538 encapsulation Methods 0.000 description 2
• 239000002702 enteric coating Substances 0.000 description 2
• 238000009505 enteric coating Methods 0.000 description 2
• 238000011049 filling Methods 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 238000005755 formation reaction Methods 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 150000004676 glycans Polymers 0.000 description 2
• 235000013773 glyceryl triacetate Nutrition 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 239000004816 latex Substances 0.000 description 2
• 230000000670 limiting Effects 0.000 description 2
• CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
• 239000008108 microcrystalline cellulose Substances 0.000 description 2
• 229940016286 microcrystalline cellulose Drugs 0.000 description 2
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
• 235000010987 pectin Nutrition 0.000 description 2
• 229920001277 pectin Polymers 0.000 description 2
• 239000001814 pectin Substances 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 239000012466 permeate Substances 0.000 description 2
• 230000000275 pharmacokinetic Effects 0.000 description 2
• XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
• 229920002401 polyacrylamide Polymers 0.000 description 2
• 229920001888 polyacrylic acid Polymers 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 150000004804 polysaccharides Polymers 0.000 description 2
• 229920002689 polyvinyl acetate Polymers 0.000 description 2
• 239000011118 polyvinyl acetate Substances 0.000 description 2
• 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
• 230000002633 protecting Effects 0.000 description 2
• 235000019423 pullulan Nutrition 0.000 description 2
• 230000000541 pulsatile Effects 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• PPBRXRYQALVLMV-UHFFFAOYSA-N styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 235000010487 tragacanth Nutrition 0.000 description 2
• 239000000196 tragacanth Substances 0.000 description 2
• 125000005591 trimellitate group Chemical group 0.000 description 2
• 230000004584 weight gain Effects 0.000 description 2
• 235000019786 weight gain Nutrition 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• BJQHLKABXJIVAM-BGYRXZFFSA-N 1-O-[(2R)-2-ethylhexyl] 2-O-[(2S)-2-ethylhexyl] benzene-1,2-dicarboxylate Chemical compound CCCC[C@H](CC)COC(=O)C1=CC=CC=C1C(=O)OC[C@H](CC)CCCC BJQHLKABXJIVAM-BGYRXZFFSA-N 0.000 description 1
• JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
• KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
• GOJCZVPJCKEBQV-UHFFFAOYSA-N 2-O-(2-butoxy-2-oxoethyl) 1-O-butyl benzene-1,2-dicarboxylate Chemical compound CCCCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCCCC GOJCZVPJCKEBQV-UHFFFAOYSA-N 0.000 description 1
• PZBLUWVMZMXIKZ-UHFFFAOYSA-N 2-O-(2-ethoxy-2-oxoethyl) 1-O-ethyl benzene-1,2-dicarboxylate Chemical compound CCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCC PZBLUWVMZMXIKZ-UHFFFAOYSA-N 0.000 description 1
• VVQNEPGJFQJSBK-UHFFFAOYSA-N 2-methyl-2-propenoic acid methyl ester Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
• CDRBDEPNXGRWGI-UHFFFAOYSA-N 2-methylprop-2-enoyloxyazanium Chemical compound CC(=C)C(=O)O[NH3+] CDRBDEPNXGRWGI-UHFFFAOYSA-N 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• GKFPPCXIBHQRQT-UHFFFAOYSA-N 6-(2-carboxy-4,5-dihydroxy-6-methoxyoxan-3-yl)oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(OC)C(C(O)=O)O1 GKFPPCXIBHQRQT-UHFFFAOYSA-N 0.000 description 1
• 229940035676 ANALGESICS Drugs 0.000 description 1
• 229940005513 ANTIDEPRESSANTS Drugs 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• 229960000510 Ammonia Drugs 0.000 description 1
• 206010003246 Arthritis Diseases 0.000 description 1
• 206010003736 Attention deficit/hyperactivity disease Diseases 0.000 description 1
• 229940067597 Azelate Drugs 0.000 description 1
• 208000008035 Back Pain Diseases 0.000 description 1
• SAOKZLXYCUGLFA-UHFFFAOYSA-N Bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
• 210000004369 Blood Anatomy 0.000 description 1
• 229950008138 Carmellose Drugs 0.000 description 1
• 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
• 210000003169 Central Nervous System Anatomy 0.000 description 1
• 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
• 240000008886 Ceratonia siliqua Species 0.000 description 1
• 229920002101 Chitin Polymers 0.000 description 1
• DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
• 241000206575 Chondrus crispus Species 0.000 description 1
• 230000037242 Cmax Effects 0.000 description 1
• 210000001072 Colon Anatomy 0.000 description 1
• 208000003311 Cytochrome P-450 Enzyme Inhibitors Diseases 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 229940099371 DIACETYLATED MONOGLYCERIDES Drugs 0.000 description 1
• DUGOZIWVEXMGBE-CHWSQXEVSA-N Dexmethylphenidate Chemical compound C([C@@H]1[C@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 DUGOZIWVEXMGBE-CHWSQXEVSA-N 0.000 description 1
• PGIBJVOPLXHHGS-UHFFFAOYSA-N Di-n-decyl phthalate Chemical compound CCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCC PGIBJVOPLXHHGS-UHFFFAOYSA-N 0.000 description 1
• KCXZNSGUUQJJTR-UHFFFAOYSA-N Di-n-hexyl phthalate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC KCXZNSGUUQJJTR-UHFFFAOYSA-N 0.000 description 1
• DOIRQSBPFJWKBE-UHFFFAOYSA-N Dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 1
• FLKPEMZONWLCSK-UHFFFAOYSA-N Diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 1
• HBGGXOJOCNVPFY-UHFFFAOYSA-N Diisononyl phthalate Chemical compound CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 description 1
• NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 1
• VJHINFRRDQUWOJ-UHFFFAOYSA-N Dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
• 206010013710 Drug interaction Diseases 0.000 description 1
• 230000037217 Elimination half-life Effects 0.000 description 1
• 229920000896 Ethulose Polymers 0.000 description 1
• 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
• 229920003136 Eudragit® L polymer Polymers 0.000 description 1
• 229920003155 Eudragit® RL 100 Polymers 0.000 description 1
• 229920003159 Eudragit® RS 100 Polymers 0.000 description 1
• 229920003137 Eudragit® S polymer Polymers 0.000 description 1
• SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
• 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• 206010022114 Injury Diseases 0.000 description 1
• 206010022437 Insomnia Diseases 0.000 description 1
• 208000009883 Joint Disease Diseases 0.000 description 1
• 206010060820 Joint injury Diseases 0.000 description 1
• DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
• 210000003734 Kidney Anatomy 0.000 description 1
• 229940067606 Lecithin Drugs 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 210000004185 Liver Anatomy 0.000 description 1
• 208000008930 Low Back Pain Diseases 0.000 description 1
• 229920002774 Maltodextrin Polymers 0.000 description 1
• 239000005913 Maltodextrin Substances 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 206010028302 Muscle disease Diseases 0.000 description 1
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• ZEYHEAKUIGZSGI-UHFFFAOYSA-N P-Anisic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-N Phenylpropanoic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
• 230000037289 Plasma half life Effects 0.000 description 1
• 230000037240 Plasma half-life Effects 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 239000004698 Polyethylene (PE) Substances 0.000 description 1
• 229940068968 Polysorbate 80 Drugs 0.000 description 1
• MZYRDLHIWXQJCQ-YZOKENDUSA-L Potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
• HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
• 206010072736 Rheumatic disease Diseases 0.000 description 1
• 239000002262 Schiff base Substances 0.000 description 1
• 150000004753 Schiff bases Chemical class 0.000 description 1
• 206010039897 Sedation Diseases 0.000 description 1
• 210000002966 Serum Anatomy 0.000 description 1
• 229920001800 Shellac Polymers 0.000 description 1
• 229940005550 Sodium alginate Drugs 0.000 description 1
• DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
• GJCOSYZMQJWQCA-UHFFFAOYSA-N Xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 description 1
• UGZICOVULPINFH-UHFFFAOYSA-N acetic acid;butanoic acid Chemical compound CC(O)=O.CCCC(O)=O UGZICOVULPINFH-UHFFFAOYSA-N 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
• 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
• 230000000996 additive Effects 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000000240 adjuvant Effects 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 239000003945 anionic surfactant Substances 0.000 description 1
• 239000000730 antalgic agent Substances 0.000 description 1
• 230000001430 anti-depressive Effects 0.000 description 1
• 239000000935 antidepressant agent Substances 0.000 description 1
• 201000006287 attention deficit hyperactivity disease Diseases 0.000 description 1
• 230000002238 attenuated Effects 0.000 description 1
• BDJRBEYXGGNYIS-UHFFFAOYSA-L azelaate(2-) Chemical compound [O-]C(=O)CCCCCCCC([O-])=O BDJRBEYXGGNYIS-UHFFFAOYSA-L 0.000 description 1
• 238000005452 bending Methods 0.000 description 1
• 229920000249 biocompatible polymer Polymers 0.000 description 1
• 238000006065 biodegradation reaction Methods 0.000 description 1
• ZDWGXBPVPXVXMQ-UHFFFAOYSA-N bis(2-ethylhexyl) nonanedioate Chemical compound CCCCC(CC)COC(=O)CCCCCCCC(=O)OCC(CC)CCCC ZDWGXBPVPXVXMQ-UHFFFAOYSA-N 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 235000021152 breakfast Nutrition 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 235000019438 castor oil Nutrition 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 239000003093 cationic surfactant Substances 0.000 description 1
• 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 239000011247 coating layer Substances 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 230000001186 cumulative Effects 0.000 description 1
• 230000001419 dependent Effects 0.000 description 1
• 238000003795 desorption Methods 0.000 description 1
• 229960001042 dexmethylphenidate Drugs 0.000 description 1
• UCVPKAZCQPRWAY-UHFFFAOYSA-N dibenzyl benzene-1,2-dicarboxylate Chemical compound C=1C=CC=C(C(=O)OCC=2C=CC=CC=2)C=1C(=O)OCC1=CC=CC=C1 UCVPKAZCQPRWAY-UHFFFAOYSA-N 0.000 description 1
• PCYQQSKDZQTOQG-UHFFFAOYSA-N dibutyl 2,3-dihydroxybutanedioate Chemical compound CCCCOC(=O)C(O)C(O)C(=O)OCCCC PCYQQSKDZQTOQG-UHFFFAOYSA-N 0.000 description 1
• PYGXAGIECVVIOZ-UHFFFAOYSA-N dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
• 229940031954 dibutyl sebacate Drugs 0.000 description 1
• 229960001826 dimethylphthalate Drugs 0.000 description 1
• ZGTMUACCHSMWAC-UHFFFAOYSA-L disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
• YCZJVRCZIPDYHH-UHFFFAOYSA-N ditridecyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCCCCC YCZJVRCZIPDYHH-UHFFFAOYSA-N 0.000 description 1
• 238000001647 drug administration Methods 0.000 description 1
• 230000000857 drug effect Effects 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 239000000806 elastomer Substances 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 238000007720 emulsion polymerization reaction Methods 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
• 230000001747 exhibiting Effects 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 229960002390 flurbiprofen Drugs 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 239000001087 glyceryl triacetate Substances 0.000 description 1
• 239000002748 glycoprotein P inhibitor Substances 0.000 description 1
• 230000036571 hydration Effects 0.000 description 1
• 238000006703 hydration reaction Methods 0.000 description 1
• 230000002209 hydrophobic Effects 0.000 description 1
• 229920001600 hydrophobic polymer Polymers 0.000 description 1
• 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
• 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
• 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 1
• 229960001680 ibuprofen Drugs 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000000968 intestinal Effects 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• VQTUBCCKSQIDNK-UHFFFAOYSA-N isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
• 229960000991 ketoprofen Drugs 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 229940035034 maltodextrin Drugs 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 150000004667 medium chain fatty acids Chemical class 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
• 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
• 238000000034 method Methods 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 238000000465 moulding Methods 0.000 description 1
• 201000010770 muscular disease Diseases 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 229920001206 natural gum Polymers 0.000 description 1
• 229920005615 natural polymer Polymers 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 239000002736 nonionic surfactant Substances 0.000 description 1
• 239000002357 osmotic agent Substances 0.000 description 1
• IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
• 239000003973 paint Substances 0.000 description 1
• 230000036961 partial Effects 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 229960000292 pectin Drugs 0.000 description 1
• 239000008016 pharmaceutical coating Substances 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 230000036231 pharmacokinetics Effects 0.000 description 1
• 229920001390 poly(hydroxyalkylmethacrylate) Polymers 0.000 description 1
• 239000004584 polyacrylic acid Substances 0.000 description 1
• 229920000867 polyelectrolyte Polymers 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 235000010408 potassium alginate Nutrition 0.000 description 1
• 239000000737 potassium alginate Substances 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• 229940002612 prodrugs Drugs 0.000 description 1
• 230000001737 promoting Effects 0.000 description 1
• 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
• 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 239000008213 purified water Substances 0.000 description 1
• 230000001105 regulatory Effects 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 239000012047 saturated solution Substances 0.000 description 1
• 230000036280 sedation Effects 0.000 description 1
• 230000001235 sensitizing Effects 0.000 description 1
• 231100000202 sensitizing Toxicity 0.000 description 1
• 239000010420 shell particle Substances 0.000 description 1
• 239000004208 shellac Substances 0.000 description 1
• 229940113147 shellac Drugs 0.000 description 1
• 235000013874 shellac Nutrition 0.000 description 1
• 231100000486 side effect Toxicity 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• 229940080313 sodium starch Drugs 0.000 description 1
• 239000007909 solid dosage form Substances 0.000 description 1
• 239000006104 solid solution Substances 0.000 description 1
• 238000005063 solubilization Methods 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 230000002269 spontaneous Effects 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 239000012086 standard solution Substances 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 230000002522 swelling Effects 0.000 description 1
• 229920001059 synthetic polymer Polymers 0.000 description 1
• 230000026676 system process Effects 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
• 239000001069 triethyl citrate Substances 0.000 description 1
• 235000013769 triethyl citrate Nutrition 0.000 description 1
• KRADHMIOFJQKEZ-UHFFFAOYSA-N tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1 KRADHMIOFJQKEZ-UHFFFAOYSA-N 0.000 description 1
• 229920001285 xanthan gum Polymers 0.000 description 1